Results 11 to 20 of about 7,770 (215)

Tranexamic Acid; A Glittering Player in the Field of Trauma [PDF]

open access: yesBulletin of Emergency and Trauma, 2020
Trauma is still the leading cause of mortality and morbidity worldwide with an estimated 5.8 million mortalities every year [1] and approximately 60 million traumatic brain injuries (TBI) annually [2]. Hemorrhage remains the most common preventable cause
Fariborz Ghaffarpasand   +4 more
doaj   +1 more source

Postoperative Low-Dose Tranexamic Acid After Major Spine Surgery: A Matched Cohort Analysis [PDF]

open access: yesNeurospine, 2020
Objective This was a retrospective, cohort study investigating the efficacy and safety of continuous low-dose postoperative tranexamic acid (PTXA) on drain output and transfusion requirements following adult spinal deformity surgery.
Lauren K. Dunn   +13 more
doaj   +1 more source

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra   +3 more
wiley   +1 more source

The Effect of Tranexamic Acid (Cyclokapron) on Post–Surgical Bleeding Following the Removal of Impacted Lower Wisdom Teeth in Healthy Individuals [PDF]

open access: yesAl-Rafidain Dental Journal, 2008
Aims: To evaluate the effect of local irrigation with tranexamic acid in minimizing post–operative bleeding following the removal of impacted lower wisdom teeth.
Rayan S. Hamid   +2 more
doaj   +1 more source

Tranexamic acid evidence and controversies: An illustrated review

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Tranexamic acid (TXA) is an antifibrinolytic agent commonly used for the treatment or prevention of bleeding. Indications for TXA are diverse, including heavy menstrual bleeding, trauma, postpartum hemorrhage, traumatic brain injury, and surgical site ...
Nicole Relke   +2 more
doaj   +1 more source

Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study [PDF]

open access: yes, 2007
Objective: Postoperative bleeding is still one of the most common complications of cardiac surgery. Antifibrinolytic agents successfully reduce bleeding, but there are controversies concerning adverse effects after their systemic use.
Barić, Davor   +7 more
core   +1 more source

Efficacy and safety of antifibrinolytics in oncological surgery: a systematic review and meta-analysis [PDF]

open access: yesRevista Brasileira de Anestesiologia, 2019
Background and objectives: The administration of antifibrinolytics has been shown to be effective in reducing blood loss and the need for transfusions in surgeries. However, few studies have evaluated these drugs in cancer surgery.
Aline Menezes Sampaio   +7 more
doaj   +3 more sources

Synthesis and Hemostatic Activity of New Amide Derivatives

open access: yesMolecules, 2022
Eight dipeptides containing antifibrinolytic agents (tranexamic acid, aminocaproic acid, 4-(aminomethyl)benzoic acid, and glycine—natural amino acids) were synthesized in a three-step process with good or very good yields.
Lukasz Banach   +9 more
doaj   +1 more source

Preventing perioperative bleeding in patients with inherited bleeding disorders [PDF]

open access: yes, 2017
Data sources: Cochrane Cystic Fibrosis and Genetic Disorders Group's Coagulopathies Trials Register, a regularly updated database informed by trials identified within electronic databases including MEDLINE.
Beacher, Nicholas, Watterson, Colin
core   +1 more source

Antifibrinolytic role of a bee venom serine protease inhibitor that acts as a plasmin inhibitor. [PDF]

open access: yesPLoS ONE, 2012
Bee venom is a rich source of pharmacologically active substances. In this study, we identified a bumblebee (Bombus ignitus) venom Kunitz-type serine protease inhibitor (Bi-KTI) that acts as a plasmin inhibitor.
Young Moo Choo   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy